Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

Prochlorperazine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prochlorperazine and what is the scope of freedom to operate?

is the generic ingredient in six branded drugs marketed by Able, Glaxosmithkline, Paddock Llc, G And W Labs, Hospira, West-ward Pharms Int, Teva Parenteral, Watson Labs, Athenex Inc, Emcure Pharms Ltd, Wyeth Ayerst, Smith And Nephew, Alpharma Us Pharms, Baxter Hlthcare, Marsam Pharms Llc, Morton Grove, Sandoz, Duramed Pharms Barr, Teva Pharms, Ivax Sub Teva Pharms, Jubilant Cadista, and Mylan, and is included in thirty-nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for prochlorperazine. Six suppliers are listed for this compound.

Summary for Generic Name: prochlorperazine

Drug Master File Entries: see list18
Suppliers / Packagers: see list6
Bulk Api Vendors: see list28
Clinical Trials: see list13
Patent Applications: see list5,297
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:prochlorperazine at DailyMed

Pharmacology for Ingredient: prochlorperazine

Drug ClassPhenothiazine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
prochlorperazine maleate
CAPSULE, EXTENDED RELEASE;ORAL011000-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Smith And Nephew
prochlorperazine edisylate
INJECTABLE;INJECTION089251-001Dec 4, 1986DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
prochlorperazine edisylate
INJECTABLE;INJECTION089903-001Aug 29, 1989APRXNoNo► Subscribe► Subscribe
Duramed Pharms Barr
prochlorperazine maleate
TABLET;ORAL040207-001May 1, 1997DISCNNoNo► Subscribe► Subscribe
prochlorperazine maleate
TABLET;ORAL040101-001Jul 19, 1996ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus